Quick Summary
Obesema 1.7mg Injection
Last updated on 29 Sep 2026 | 06:36 AM (IST)
₹2273
MRP: ₹2500
(You Save ₹227)
1 PREFILLED PEN(s)
Obesema 1.7mg Injection
Salt Composition
SEMAGLUTIDEMarketer
ALKEM LABORATORIES LTD
Prepaid Only. Non-Returnable.
9% OFF
₹2273
MRP: ₹2,500.00
Inclusive of all taxes
9% Off
Salt Composition
SEMAGLUTIDEMarketer
ALKEM LABORATORIES LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Hepaglide 1.7mg Injection
ALKEM LABORATOR...
₹ 568.25/injection
0% cheaper
Noveltreat 1.7mg Injection
SUN PHARMACEUTI...
₹ 721.25/injection
27% costlier
Semawin 1.7mg Pen injection
INTAS PHARMACEU...
₹ 777.75/injection
37% costlier
Sundae Pro 1.7mg Pen Injection
ERIS LIFESCIENC...
₹ 954.50/injection
68% costlier
Better Service Satisfied Customers
Introduction
Obesema 1.7mg Injection contains Semaglutide, a GLP-1 receptor agonist. It is a prescription injection used for type 2 diabetes mellitus and chronic weight management in eligible adults.
The 1.7 mg strength is part of the gradual Semaglutide dose-escalation pathway for weight management and may be continued or adjusted according to the prescribed treatment plan.
Uses
Obesema 1.7mg Injection is used:
To improve blood sugar control in adults with type 2 diabetes mellitus, along with diet and exercise.
For chronic weight management in eligible adults with obesity or overweight with a weight-related health condition.
How Obesema 1.7mg Injection Works
Semaglutide activates GLP-1 receptors involved in blood glucose and appetite regulation. It increases insulin release when glucose is elevated and reduces glucagon release.
It also slows stomach emptying and increases fullness, which can help reduce food intake.
Interaction of Obesema 1.7mg Injection with Other Medicines
Tell your doctor about all medicines you take.
Insulin and sulfonylureas: May increase the risk of low blood sugar.
Oral medicines: Delayed stomach emptying can affect the absorption of some oral medicines.
Other Semaglutide or GLP-1 receptor agonists: Do not combine them unless specifically advised.
Storage Conditions
Store Obesema according to the product instructions.
Refrigerate at 2°C to 8°C before use unless otherwise specified.
Do not freeze.
Protect from light.
Keep out of the sight and reach of children.
How to Use
Obesema 1.7mg Injection is generally administered once weekly by subcutaneous injection into the abdomen, thigh or upper arm.
The dose should be increased gradually and only according to your doctor's instructions. Do not increase or decrease the dose yourself.
Safety Advice
Pregnancy
Semaglutide should not be used for weight management during pregnancy. It should generally be stopped at least 2 months before planned pregnancy.
Breast Feeding
Semaglutide should not be used while breastfeeding because its safety for the breastfed baby has not been established.
Lungs
Tell your doctor before surgery or deep sedation because Semaglutide delays stomach emptying and may increase aspiration risk.
Liver
Tell your doctor if you have liver disease.
Alcohol
Discuss alcohol consumption with your doctor.
Driving
Dizziness or low blood sugar may affect your ability to drive.
Side Effects
Common side effects:
Nausea
Vomiting
Diarrhoea
Constipation
Abdominal pain
Headache
Indigestion
Dizziness
Abdominal distension
Serious side effects:
Pancreatitis
Severe allergic reactions
Gallbladder problems
Dehydration
Hypoglycaemia with insulin or sulfonylureas
Vision changes
Symptoms of thyroid tumours
Seek medical attention promptly if serious symptoms occur.
Expert Tips
Do not start or increase the 1.7 mg dose without medical advice.
Follow the complete dose-escalation schedule prescribed for you.
Use the injection on the same day each week.
Rotate injection sites.
Use a new needle for every injection.
Do not share the pen.
Maintain the diet and physical activity plan recommended by your doctor.
Report severe abdominal pain, persistent vomiting or vision changes promptly.
FAQs
Q1.
What is Obesema 1.7mg Injection used for?
It is used for type 2 diabetes mellitus and chronic weight management in eligible adults.
Q2.
Is Obesema 1.7mg a starting dose?
No. Semaglutide is generally started at a lower dose and increased gradually.
Q3.
How often should I use Obesema 1.7mg Injection?
It is generally administered once weekly.
Q4.
Can Obesema 1.7mg cause nausea?
Yes. Nausea is one of the common side effects of Semaglutide and can be more noticeable during dose escalation.
Q5.
Can I use Obesema 1.7mg with another GLP-1 medicine?
No. Do not combine it with another Semaglutide-containing medicine or GLP-1 receptor agonist unless your doctor specifically advises you to do so.
Fact Box
Molecule name: | Semaglutide |
Therapeutic class: | Antidiabetic agent / Anti-obesity medicine |
Pharmacological class: | GLP-1 receptor agonist |
Indications: | Type 2 diabetes mellitus, chronic weight management |
References
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Vishishta
M.Sc Microbiology
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 29 Sep 2026 | 06:36 AM (IST)
Want to know more?
Read Our Editorial Policy
